Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Prothrombin mutation conveying antithrombin resistance.

Lotta LA, Martinelli I, Peyvandi F.

N Engl J Med. 2012 Sep 13;367(11):1069; author reply 1069-70. doi: 10.1056/NEJMc1208510#SA1. No abstract available.

PMID:
22970962
2.

Prothrombin mutation conveying antithrombin resistance.

Simioni P, Campello E, Spiezia L.

N Engl J Med. 2012 Sep 13;367(11):1069; author reply 1069-70. doi: 10.1056/NEJMc1208510#SA2. No abstract available.

PMID:
22970963
3.

Thrombosis from a prothrombin mutation conveying antithrombin resistance.

Miyawaki Y, Suzuki A, Fujita J, Maki A, Okuyama E, Murata M, Takagi A, Murate T, Kunishima S, Sakai M, Okamoto K, Matsushita T, Naoe T, Saito H, Kojima T.

N Engl J Med. 2012 Jun 21;366(25):2390-6. doi: 10.1056/NEJMoa1201994.

4.

Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.

Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.

Haematologica. 2000 Dec;85(12):1271-6.

5.

[Portal and mesenteric vein thrombosis associated to a prothrombin gene mutation].

Calvo Romero JM.

Rev Esp Enferm Dig. 2008 Apr;100(4):245-6. Spanish. No abstract available.

6.

G20210A prothrombin gene mutation identified in patients with venous leg ulcers.

Jebeleanu G, Procopciuc L.

J Cell Mol Med. 2001 Oct-Dec;5(4):397-401.

7.

The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.

N Engl J Med. 1999 Sep 9;341(11):801-6.

8.

Factor II gene(prothrombin G20210A)mutation and neonatal cerebrovenous thrombosis.

Swarte R, Appel I, Lequin M, van Mol C, Govaert P.

Thromb Haemost. 2004 Oct;92(4):719-21. No abstract available.

PMID:
15499693
9.

Two additional homozygous patients for the 20210 prothrombin polymorphism with no venous thrombosis.

Girolami A, Simioni P, Tormene D, Scarano L.

Thromb Res. 1999 Dec 1;96(5):415-7. No abstract available.

PMID:
10605957
10.

Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients.

Rodrigues CA, Rocha LK, Morelli VM, Franco RF, Lourenço DM.

J Thromb Haemost. 2004 Jul;2(7):1211-2. No abstract available.

11.

G to A 20210 prothrombin polymorphism and venous thrombosis: simple association or causal relationship?

Girolami A, Simioni P, Girolami B, Scarano L.

Clin Appl Thromb Hemost. 2000 Jul;6(3):135-8. Review. No abstract available.

PMID:
10898272
12.

[A new mutation in the prothrombin gene (G20210A) and the risk for venous and arterial thromboembolism].

Misgav M, Eldor A, Berliner S.

Harefuah. 2000 Jul;139(1-2):51-6. Review. Hebrew. No abstract available.

PMID:
10979454
13.

[Factor V Leiden and PTG20210A gene mutation in patients with venous thrombosis and healthy blood donors].

Bai C, Pan J, Li X.

Zhonghua Yi Xue Za Zhi. 1999 Dec;79(12):900-2. Chinese.

PMID:
11715503
14.

Prevalence of the prothrombin gene G20210A mutation in Azerbaijan.

Togrul J, Rustamov R, Gurgey A, Altay S, Altay C.

Br J Haematol. 2000 Mar;108(4):887-8. No abstract available.

PMID:
10858039
16.

Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.

Castaman G, Tosetto A, Simioni M, Ruggeri M, Madeo D, Rodeghiero F.

Thromb Haemost. 2001 Sep;86(3):804-8.

PMID:
11583311
17.

[Cerebral venous thrombosis and familial prothrombin gene G20210a mutation].

Verdelho A, Ferro JM, Palmeiro A, Antunes C.

Rev Neurol. 2001 Aug 16-31;33(4):335-8. Spanish.

PMID:
11588727
18.

Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study.

Young G, Manco-Johnson M, Gill JC, Dimichele DM, Tarantino MD, Abshire T, Nugent DJ.

J Thromb Haemost. 2003 May;1(5):958-62.

19.

It is not sure yet whether the nt 20210 G to A prothrombin polymorphism represents a cause of familial venous thrombophilia.

Girolami A, Zanon E, Tormene D, Girolami B, Carraro G.

Blood Coagul Fibrinolysis. 1999 Sep;10(6):399-401. Review. No abstract available.

PMID:
10493223
20.

Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of factor V Leiden or prothrombin G20210A.

Ordóñez AJ, Carreira JM, Alvarez CR, Rodríguez JM, Alvarez MV, Coto E.

Thromb Haemost. 2000 Feb;83(2):352-4. No abstract available.

PMID:
10739402

Supplemental Content

Support Center